Careray Digital Medical Technology Co. Ltd. Class A

As of June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A carries a market capitalization of 4.49B, placing it among publicly traded companies globally. Its enterprise value stands at 4.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Careray Digital Medical Technology Co. Ltd. Class A's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A has 88.13M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 13.63, and the price-to-book ratio stands at 5.36.

These figures are as of June 30, 2026. The EV/Sales ratio of 14.32 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.65B versus a market cap of 4.49B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A maintains a current ratio of 1.92, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.63, indicating elevated leverage, while an interest coverage ratio of -35.83 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A posted a negative return on equity (ROE) of -3.32, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.32, reflecting losses generated across the asset base. The company generates approximately 1.15M in revenue per employee across its workforce of 282.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.64 indicates how many times Careray Digital Medical Technology Co. Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A recorded 131,326.83 in income tax expense. The company reported a pretax loss of -30.59M and -28.18M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Careray Digital Medical Technology Co. Ltd. Class A's stock has gained approximately 14.19% over the past 52 weeks. The 50-day moving average sits at 39.60, while the 200-day moving average is 50.72.

Over the twelve months ended June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A generated 325.10M in revenue and converted that into -28.18M in net income, yielding earnings per share of -0.35. EBITDA reached -30.20M, while operating income came in at -4.75M.

As of June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A holds 269.78M in cash and equivalents against 366.13M in total debt, resulting in a net debt position of 85.25M. Total book value stands at 838.00M, with working capital of 278.01M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A posted a gross margin of 35.55, reflecting its pricing power and cost economics. The operating margin of -1.46 and net profit margin of -8.67 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A paid dividends of 0.01 per share. The dividend payout ratio of -1.87 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -6.67, meaning Careray Digital Medical Technology Co. Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Careray Digital Medical Technology Co. Ltd. Class A has an Altman Z-Score of 5.52, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.